Concepedia

Juin Park

JP

Statistics

Publications

2

Citations

56

H-Index

2

Active since

2023

Affiliations

Yonsei University(Current)

Juin Park is an author at Yonsei University specializing in cancer immunotherapy, molecular oncology, and human epidermal growth factor receptor 2-targeted therapy.

ORCID

Publications per year

2023–2023

2

Publications

2

Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer

Chang Gon Kim, Minkyu Jung, Hyo Song Kim et al. · Journal of Clinical Oncology · 2023 · 44 citations · Full text

, , +14

Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer

Juin Park, Sun Kyoung Kang, Woo Sun Kwon et al. · Scientific Reports · 2023 · 12 citations · Full text

, , +17

1–2 of 2